Ausgabe 6/2017
Inhalt (27 Artikel)
The “reset button” revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients
Frederik A. Verburg, Markus Luster, Luca Giovanella, Michael Lassmann, Carlo Chiesa, Nicolas Chouin, Glenn Flux
Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option
Jérôme Clerc, Frederik A. Verburg, Anca M. Avram, Luca Giovanella, Elif Hindié, David Taïeb
Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy
Arnoldo Piccardo, Matteo Puntoni, Gianluca Bottoni, Giorgio Treglia, Luca Foppiani, Mattia Bertoli, Ugo Catrambone, Anselmo Arlandini, Bassam Dib, Vania Altrinetti, Michela Massollo, Irene Bossert, Manlio Cabria, Francesco Bertagna, Luca Giovanella
Measuring the actual I-131 thyroid uptake curve with a collar detector system: a feasibility study
Peter Brinks, Koen Van Gils, Ellen Kranenborg, Jules Lavalaye, Dennis Dieckens, Jan B. A. Habraken
68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour
Christian Uprimny, Alexander Stephan Kroiss, Clemens Decristoforo, Josef Fritz, Elisabeth von Guggenberg, Dorota Kendler, Lorenza Scarpa, Gianpaolo di Santo, Llanos Geraldo Roig, Johanna Maffey-Steffan, Wolfgang Horninger, Irene Johanna Virgolini
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095
Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, Thomas Armor, Walter Mier, Fabian Spohn, Nils Debus, Tim Holland-Letz, John Babich, Clemens Kratochwil
Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer
Sebastian Schmuck, Stefan Nordlohne, Christoph-A. von Klot, Christoph Henkenberens, Jan M. Sohns, Hans Christiansen, Hans-Jürgen Wester, Tobias L. Ross, Frank M. Bengel, Thorsten Derlin
Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers
Satoshi Takeuchi, Eric M. Rohren, Reham Abdel-Wahab, Lianchun Xiao, Jeffrey S. Morris, Homer A. Macapinlac, Manal M. Hassan, Ahmed O. Kaseb
Head-to-head comparison between 18F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas
Céline Heimburger, Francis Veillon, David Taïeb, Bernard Goichot, Sophie Riehm, Julie Petit-Thomas, Gerlinde Averous, Marcela Cavalcanti, Fabrice Hubelé, Gerard Chabrier, Izzie Jacques Namer, Anne Charpiot, Alessio Imperiale
Post-treatment PET/CT and p16 status for predicting treatment outcomes in locally advanced head and neck cancer after definitive radiation
Musaddiq J. Awan, Pierre Lavertu, Chad Zender, Rod Rezaee, Nicole Fowler, Lilit Karapetyan, Michael Gibson, Jay Wasman, Peter Faulhaber, Mitchell Machtay, Min Yao
The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer
Inne J. den Toom, Annelies van Schie, Stijn van Weert, K. Hakki Karagozoglu, Elisabeth Bloemena, Otto S. Hoekstra, Remco de Bree
18F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?
Julian Kirchner, Cornelius Deuschl, Johannes Grueneisen, Ken Herrmann, Michael Forsting, Philipp Heusch, Gerald Antoch, Lale Umutlu
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti, Jamshed Bomanji, Francesco Ceci, Steven Cho, Frederik Giesel, Uwe Haberkorn, Thomas A. Hope, Klaus Kopka, Bernd J. Krause, Felix M. Mottaghy, Heiko Schöder, John Sunderland, Simon Wan, Hans-Jürgen Wester, Stefano Fanti, Ken Herrmann
Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging
Simon Kaller, Michael Rullmann, Marianne Patt, Georg-Alexander Becker, Julia Luthardt, Johanna Girbardt, Philipp M. Meyer, Peter Werner, Henryk Barthel, Anke Bresch, Thomas H. Fritz, Swen Hesse, Osama Sabri
Neural correlates of the popular music phenomenon: evidence from functional MRI and PET imaging
Qiaozhen Chen, Ying Zhang, Haifeng Hou, Fenglei Du, Shuang Wu, Lin Chen, Yehua Shen, Fangfang Chao, June-key Chung, Hong Zhang, Mei Tian
PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans
Ansel T. Hillmer, Songye Li, Ming-Qiang Zheng, Matthias Scheunemann, Shu-fei Lin, Nabeel Nabulsi, Daniel Holden, Richard Pracitto, David Labaree, Jim Ropchan, Rodrigo Teodoro, Winnie Deuther-Conrad, Irina Esterlis, Kelly P. Cosgrove, Peter Brust, Richard E. Carson, Yiyun Huang
Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study
Raphaëlle Richieri, Damien Jouvenoz, Antoine Verger, Patrick Fiat, Laurent Boyer, Christophe Lançon, Eric Guedj
Central noradrenaline transporter availability in highly obese, non-depressed individuals
Swen Hesse, Georg-Alexander Becker, Michael Rullmann, Anke Bresch, Julia Luthardt, Mohammed K. Hankir, Franziska Zientek, Georg Reißig, Marianne Patt, Katrin Arelin, Donald Lobsien, Ulrich Müller, S. Baldofski, Philipp M. Meyer, Matthias Blüher, Mathias Fasshauer, Wiebke K. Fenske, Michael Stumvoll, Anja Hilbert, Yu-Shin Ding, Osama Sabri
Imaging the DNA damage response with PET and SPECT
James C. Knight, Sofia Koustoulidou, Bart Cornelissen
An update on the role of PET/CT and PET/MRI in ovarian cancer
Benjapa Khiewvan, Drew A. Torigian, Sahra Emamzadehfard, Koosha Paydary, Ali Salavati, Sina Houshmand, Thomas J. Werner, Abass Alavi
Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging
Paolo Zanotti-Fregonara, Clément Morgat, Christophe Champion, Elif Hindié
The gross picture: intraindividual tumour heterogeneity in a patient with nonsecretory multiple myeloma
Constantin Lapa, Andreas Schirbel, Samuel Samnick, Katharina Lückerath, K. Martin Kortüm, Stefan Knop, Hans-Jürgen Wester, Andreas K. Buck, Martin Schreder
213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
Mike Sathekge, Otto Knoesen, Marian Meckel, Moshe Modiselle, Mariza Vorster, Sebastian Marx
Juliano Cerci, Stefano Fanti, Dominique Delbeke (Eds): Oncological PET/CT with Histological Confirmation
Valentina Piscopo, Luigi Mansi
Atlas of Anatomy - Third Edition. Anne M. Gilroy and Brian R. MacPherson (Eds) On the basis of the work of Michael Schuenke, Erik Schulte and Udo Schumaker
Gennaro Melluso, Luigi Mansi
In memoriam Professor Jan van der Schoot (1927–2017)
Ellinor Busemann Sokole, Renato Valdés Olmos